Breaking Gene Therapy News
-
Science with Chris Smith: Gene therapy for MS - ABC Online
Sep 21, 2017 | 22:56 pmABC OnlineScience with Chris Smith: Gene therapy for MSABC OnlineMore than two million people are living with Multiple Sclerosis worldwide, with women affected up to three times more frequently than men. And now, researchers in the US say they've developed a gene therapy technique that can halt the progression of a ...
Read more... -
OHSU gene therapy pioneer Shoukhrat Mitalipov headlines Health Care of the Future event - Portland Business Journal
Sep 21, 2017 | 20:34 pmOHSU gene therapy pioneer Shoukhrat Mitalipov headlines Health Care of the Future eventPortland Business JournalWe are gearing up for the Business Journal's fourth annual Health Care of the Future event. This year's half-day conference takes place the morning of Sept. 29 at the Hilton Hotel in downtown Portland (register here). Last year's event drew more than ...
Read more... -
Unique gene therapy prevents, reverses multiple sclerosis in animal model - University of Florida
Sep 21, 2017 | 20:03 pmUniversity of FloridaUnique gene therapy prevents, reverses multiple sclerosis in animal modelUniversity of FloridaMultiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops the disease's immune response in mouse models, University of Florida Health researchers have found. By combining a brain-protein gene and an existing ...and more »
Read more... -
Gene therapy reverses symptoms, slows progression of MS in mice - FierceBiotech
Sep 21, 2017 | 18:55 pmGene therapy reverses symptoms, slows progression of MS in miceFierceBiotechThe gene therapy alone reversed symptoms in mice with early-stage MS, but combining it with an approved immunosuppressive drug reversed symptoms in most mice with end-stage disease. Share Facebook Twitter LinkedIn Email Print. A gene therapy ...
Read more... -
Avrobio Developing a Gene Therapy for Pompe Disease - Rare Disease Report
Sep 21, 2017 | 17:57 pmRare Disease ReportAvrobio Developing a Gene Therapy for Pompe DiseaseRare Disease ReportAvrobio Inc. announced today that it will be expanding its gene therapy pipeline to include Pompe disease. This will be the third gene therapy the company has in its pipeline to treat a rare lysosomal storage disease; the other 2 programs are for Fabry ...and more »
Read more... -
Gene Therapy Sales Market in United States 2017 – Avalanche Bio , Spark Therapeutics, Dimension Therapeutics ... - DailyCommerceNews
Sep 21, 2017 | 14:29 pmDailyCommerceNewsGene Therapy Sales Market in United States 2017 – Avalanche Bio , Spark Therapeutics, Dimension Therapeutics ...DailyCommerceNewsThe up-to-date research report on United States Gene Therapy Sales Market portrays a detailed fundamental market overview which is fueled by deep research to acquaint the users with latest Gene Therapy Sales market trends, current market overview and ...and more »
Read more... -
AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease - Business Wire (press release)
Sep 21, 2017 | 14:05 pmAVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe DiseaseBusiness Wire (press release)CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene therapies for rare diseases, today announced the expansion of its pipeline to Pompe disease. This pre-clinical ...and more »
Read more... -
CF Foundation Affiliate Awards $3M to Advance Gene Therapy Candidate to Trials - Cystic Fibrosis News Today
Sep 21, 2017 | 14:00 pmCystic Fibrosis News TodayCF Foundation Affiliate Awards $3M to Advance Gene Therapy Candidate to TrialsCystic Fibrosis News Today4D Molecular Therapeutics (4DMT) announced it has secured funding to complete studies necessary for its gene therapy candidate for cystic fibrosis (CF), 4D-710, to be tested in people. The therapy is composed of a what 4DMT describes as an advanced ...
Read more... -
Even at $500K, Gene Therapy Could Be a Bargain for Some Diseases - MIT Technology Review
Sep 21, 2017 | 12:01 pmMIT Technology ReviewEven at $500K, Gene Therapy Could Be a Bargain for Some DiseasesMIT Technology ReviewA one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime. by Emily Mullin; September 21, 2017; Novartis's recently approved gene therapy for leukemia, called Kymriah ...and more »
Read more... -
Novel Gene Therapy and Antisense Drugs to Offer Effective Cancer Cure - TMR Research Blog (press release) (blog)
Sep 21, 2017 | 11:57 amTMR Research Blog (press release) (blog)Novel Gene Therapy and Antisense Drugs to Offer Effective Cancer CureTMR Research Blog (press release) (blog)San Francisco, California, September 21, 2017: The demand for gene therapy and antisense drug is rising at a very high pace in response to the increasing incidence of cancer witnessed worldwide. Besides this, high cholesterol and increasing incidence ...and more »
Read more...